methenmadinone acetate methenmadinone acetate methenmadinone acetate (mma), also known as methylenedehydroacetoxyprogesterone (mdap) and sold under the brand names superlutin and antigest, is a progestin medication which was developed in czechoslovakia in the 1960s. it is the c17α acetate ester of methenmadinone. methenmadinone acetateclinical datatrade namessuperlutin, antigestother namessuperlutin; superlutine; mma; methylene­dehydroacetoxy­progesterone; mdap; 17α-hydroxy-16-methylene-δ6-progesterone 17α-acetate; 17α-acetoxy-16-methylenepregna-4,6-diene-3,20-dioneroutes ofadministrationby mouthdrug classprogestogen; progestin; progestogen esteridentifiers iupac name phenanthren-17-yl] acetate cas number805-84-5pubchem cid188952chemspider164183uniikur23m82tzcomptox dashboard (epa)dtxsid701001282 chemical and physical dataformulac24h30o4molar mass382.500 g·mol−13d model (jsmol)interactive image smiles cc(=o)1(c(=c)c21(cc32c=cc4=cc(=o)cc34c)c)oc(=o)c inchi inchi=1s/c24h30o4/c1-14-12-21-19-7-6-17-13-18(27)8-10-22(17,4)20(19)9-11-23(21,5)24(14,15(2)25)28-16(3)26/h6-7,13,19-21h,1,8-12h2,2-5h3/t19-,20+,21+,22+,23+,24+/m1/s1key:uxrdajmoogeiaq-ckozhmepsa-n mma given orally shows about 13-fold the progestogenic activity of parenteral progesterone in animal bioassays. analogues of methenmadinone acetate include methenmadinone caproate (mmc), which was studied in combination with estradiol valerate as a combined injectable contraceptive (tentative brand name lutofollin); chlormethenmadinone acetate (chlorsuperlutin; sch-12600; 6-chloro-mma), which has been used in combination with mestranol in birth control pills (brand names biogest, sterolibrin, antigest b) and in veterinary medicine (brand name agelin); bromethenmadinone acetate (bromsuperlutin; 6-bromo-mma), which was assessed but was never marketed; and melengestrol acetate (methylsuperlutin; 6-methyl-mma), which is used in veterinary medicine.